Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lux Biosciences, Inc.
Age
13–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Documented history of non-infectious anterior, anterior and intermediate- or panuveitis
Currently uncontrolled uveitis for a minimum of 2 weeks despite use of oral and/or topical corticosteroid,or subjects who are intolerant of local corticosteroid therapy due to the development of an ocular hypertensive response or subjects for whom oral corticosteroid is contraindicated.
Grade of 2+ or higher for anterior chamber cells at time of enrollment
Considered by the investigator to require corticosteroid-sparing therapy.
Subjects not planning to undergo elective ocular surgery during the study
You may not be if
Uveitis of infectious etiology
Presence of an ocular toxoplasmosis scar
An immune suppression regimen that includes an alkylating agent within the previous 90 days
